United States: 2024 Guide To DOJ And HHS OIG Guidance On Effective Compliance Programs - Akin Gump Strauss Hauer & Feld LLP
The Department of Health & Human Services' Office of Inspector General (HHS OIG) and U.S. Department of Justice (DOJ) have published important guidance and recommendations for pharmaceutical...
Full Article